Neobiocon

Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs

Research Innovation Pharmaceuticals medical Biocon best biopharma company top biopharma company Biologics Research services Head and neck cancer breast cancer cancer drugs clinical trials Contract Manufacturing affordable medicines affordable drugs biocon share market price pharma biotech biotechnology biopharmaceuticals diabetes insulin insulin analogs human insulin oral insulin immunosuppressant immunotherapy Psoriasis Bio product Branded Formulations Biosimilar Small Molecules fermentation monoclonal antibody recombinant proteins egfr gcsf orlistat glargine peptides Aspart Lispro metabolic drug drug manufacturing stalins Pharmaceutical Contract Manufacturing large scale producers global manufacturers APIs Formulations Injectable Discovery Novel Molecules fusion proteins Integrated Branded Formulations diabetology oncology nephrology cardiology comprehensive care Insugen Basalog Canmab Tacrograf Biomab EGFR Renodapt S Psorid Cimivir L Renodapt Insugen N Daclawin Tbis Picon Cymgal Calpsor C Abstet Thinla Evertor Advacan Rapacan Aretha Bionesp Fosaport Genxtor Calpsor Inter acting fast acting Long acting Trastuzumab recombinant Tacrolimus Oth mab antineoplastics Mycophenolic acid Ciclosporin Ledipasvir sofosbuvir Mycophenolate mofetil Intermediate acting Daclatasvir Tacrolimus topical Pimecrolimus Valganciclovir Oth clobetasol antiinf co Abiraterone Heparin Everolimus Sirolimus Azathioprine Darbepoetin prep Fosaprepitant meglumine Oth pki antineoplastics Calcipotriol